Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03657251 · ClinicalTrials.gov registry record
MMRF CureCloud Research Initiative
A clinical trial, sponsored by Multiple Myeloma Research Foundation.
- Terminated
- Registry status
- 1,105
- Enrollment target
NCT03657251: Clinical Trial study, sponsored by Multiple Myeloma Research Foundation.
NCT03657251 is a clinical trial that was terminated before completion, run by Multiple Myeloma Research Foundation. The registered enrollment target is 1,105 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03657251 was terminated before completion, sponsored by Multiple Myeloma Research Foundation.
- TERMINATED
- Registry status
- 1,105 participants
- Enrollment target
Study Summary
The MMRF CureCloud Research Initiative, a Direct-to-Patient Research effort aimed at enrolling 5,000 individuals from whom comprehensive molecular and immune analyses will be generated from blood specimens and the resulting data aggregated with the correlating clinical information. Blood will be collected from all participants after electronic online consenting via a mailed blood kit designed for a mobile phlebotomy appointment. Through the consenting process, participants will also be authorizing collection of their electronic medical records information.
Primary Outcome
Patients that have been diagnosed with active Multiple Myeloma will be asked to share their clinical information and blood samples to help scientists and researchers understand these conditions better. The study will use submitted blood samples to perform comprehensive research that will include, among others, genomic and immune characterization, as well as collect past and present medical records to combine and compare with the blood sample analysis.
Interventions
- GENETIC liquid biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,105 participants |
| Start Date | 2020-07-14 |
| Est. Completion | 2023-12-31 |
Why NCT03657251 stopped before completion
NCT03657251 is an observational study that tracks outcomes without assigning an intervention. Its 1,105 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which liquid biopsy is the first listed.
NCT03657251 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03657251 about?
NCT03657251 is a clinical study titled "MMRF CureCloud Research Initiative". The MMRF CureCloud Research Initiative, a Direct-to-Patient Research effort aimed at enrolling 5,000 individuals from whom comprehensive molecular and immune analyses will be generated from blood specimens and the resulting data aggregated with the correlating clinical information. Blood will be col...
What is the current status of trial NCT03657251?
This trial is currently terminated. The enrollment target is 1,105 participants. The study started on 2020-07-14. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT03657251?
The interventions under investigation include: liquid biopsy (GENETIC).
Who is sponsoring clinical trial NCT03657251?
This trial is sponsored by Multiple Myeloma Research Foundation, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00710112 · 1,100 participants
Genetic Variants and Susceptibility to Diseases of Prematurity in Very Low Birth-Weight Infants
- NCT02688517 · 1,100 participants
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
- NCT04743765 · 1,100 participants · NA
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
- NCT05638581 · 1,100 participants · Phase 3
Trauma Resuscitation With Low-Titer Group O Whole Blood or Products
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI